U.S. markets closed

Takeda Pharmaceutical Company Limited (TKPHF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
29.290.00 (0.00%)
At close: 03:18PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close29.29
Bid0.00 x 0
Ask0.00 x 0
Day's Range29.29 - 29.29
52 Week Range26.03 - 39.90
Avg. Volume17,477
Market Cap45.89B
Beta (5Y Monthly)1.09
PE Ratio (TTM)11.13
EPS (TTM)2.63
Earnings DateN/A
Forward Dividend & Yield1.66 (5.66%)
Ex-Dividend DateMar 30, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for TKPHF

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    ENDP: What does Argus have to say about ENDP?ENDO INTERNATIONAL PLC has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • Motley Fool

    3 Healthcare Stocks With High Dividends

    So far 2022 has been brutal for growth stocks. A good place to hide might be the healthcare sector. It's a great defensive play, as healthcare is as basic as food. And these stocks all pay a nice dividend.

  • Business Wire

    Takeda Named Global Top Employer for Fifth Consecutive Year

    OSAKA, Japan & CAMBRIDGE, Mass., January 20, 2022--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced that it was one of only 11 companies to achieve global Top Employer® certification for 2022, marking the fifth consecutive year that it has been recognized for outstanding people policies and practices worldwide. In addition to the global certification, Takeda is also recognized as a Top Employer across four regions and 39 countries, reinforcing its steadfast co


    Sippican Capital Advisors Buys Coterra Energy Inc, DaVita Inc, Physicians Realty Trust, Sells ...

    Investment company Sippican Capital Advisors (Current Portfolio) buys Coterra Energy Inc, DaVita Inc, Physicians Realty Trust, Ncino Inc, Triumph Bancorp Inc, sells TriState Capital Holdings Inc, Central Securities Corp, Adobe Inc, Vulcan Materials Co, Berkshire Hathaway Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Sippican Capital Advisors.